Evidence suggests the J&J shot might have an edge in durability over Pfizer’s and Moderna’s vaccines.
Pfizer and Moderna last week asked the FDA to authorize fourth doses of their vaccines. Meanwhile, a new study shows protection from one J&J shot lasts at least six monthsWhen the early COVID-19 vaccine trial results came out, an important indicator of success couldn’t yet be assessed: durability.
Those initial studies were just three to four months — too short to determine how long protection lasts. But now, that question is gaining renewed attention as public health officials weigh the
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
'Reassuring' data suggests the J&J vaccine may still have a role to play against Covid-19The US public and even some health experts may have underestimated the Covid-19 vaccine made by Janssen, a division of Johnson & Johnson, new data shows
Lire la suite »
Arizona's largest COVID-19 testing provider growing concerned over funding for uninsured patientsArizona's largest COVID-19 testing provider, Embry Health, is growing concerned over funding for uninsured patients as pandemic funding from Congress wasn't given out after all.
Lire la suite »
Disney closes Shanghai park as COVID-19 cases surgeDisney Co. closed its Shanghai theme park Monday as Chinese authorities tried to control the city's biggest coronavirus flareup in two years, while the southern business center of Shenzhen allowed shops and offices to reopen after a weeklong closure.
Lire la suite »
EXPLAINER: Justice Clarence Thomas hospitalized, not with COVID-19The 73-year-old justice has been vaccinated and boosted against COVID-19, along with the other eight justices, the court has said.
Lire la suite »
After the omicron surge in early 2022, COVID-19 cases declined in Texas schoolsStudent and staff COVID-19 cases declined after districts reported their highest levels in January since the pandemic began. But the data is incomplete and likely an undercount.
Lire la suite »
Fears of COVID-19 resurgence in the US grow as officials warn of potential upticksOver the last week, virus-related hospitalizations in the U.S. have plateaued.
Lire la suite »